市場調查報告書
商品編碼
1439400
生命徵象監測儀:全球市場考量、競爭格局、市場預測(2030 年)Vital Sign Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球生命徵象監測儀市場規模到2023年將達到81.9億美元,到2030年將達到129.6億美元,預計2024-2030年期間複合年增長率為7.94%。 導致生命徵象監測儀需求增加的主要因素包括世界人口老化的增加以及呼吸系統疾病和心血管疾病等各種與生活方式相關的疾病的日益流行。 此外,主要製造商不斷努力利用先進技術開發生命徵象監測設備,並提高其產品組合的認可度,都有助於生命徵象監測設備的成長。
生命徵象監測儀市場動態
近年來,由於世界人口老化的加劇,生命徵象監測儀的發展勢頭強勁。 這是因為老年人罹患各種慢性疾病的風險較高,因此需要持續測量其重要器官的表現。 例如,根據聯合國發布的2020年世界人口老化統計數據,同年全球65歲以上人口約為7.27億。 《Highlight》也預計,到 2050 年,全球老年人口將翻一番,達到 15 億以上。
此外,生活型態相關疾病的流行也是生命徵象監測儀需求增加的主要因素之一。 據世界衛生組織(WHO)稱,高血壓是一種嚴重的生活方式疾病,會顯著增加心臟、大腦和腎臟等疾病的風險。 此外,根據世界衛生組織發布的2022年統計數據,全球約12.8億30歲至79歲的成年人患有高血壓。
此外,預計各種生命徵象監測設備的產品核准增加也將加強生命徵象監測設備市場。 例如,2022 年 2 月 10 日,CardiacSense 獲得了一款醫療級手錶的 CE 標誌,可以檢測和遠端監測心房顫動 (AF) 和心率變異性 (HRV)。
因此,所有上述因素預計將在預測期內加強全球生命徵象監測儀市場。
某些因素(例如與某些產品類型相關的高成本以及某些監測設備的使用者準備程度或反應遲鈍)預計將限制生命徵象監測器市場的成長。
此外,前所未有的 COVID-19 大流行對生命徵象監測儀市場產生了積極影響。 這是因為 FDA 近年來擴大了生命體徵監測儀的使用,以便在 COVID-19 緊急情況下實現遠端患者護理,從而最大限度地降低 COVID-19 暴露風險並減少醫院就診次數。 此外,這種流行病還使當地製造商能夠推出遠端測量患者體溫和呼吸頻率等數據的新產品。 例如,2020年6月,印度DetelPro推出了一款非常便宜的紅外線測溫儀。
生命徵象監測儀細分市場分析
在生命徵象監測產品領域,血壓監測儀、體溫監測儀、脈搏血氧儀等獨立監測儀預計將在未來幾年佔據主要市場份額。 這是因為獨立設備在市場上隨處可見。 此外,獨立的遠端生命徵象監測設備也可以在櫃檯購買,這也擴大了生命徵象監測領域的市場。
此外,COVID-19 的突然爆發也增加了對脈搏血氧計的需求。 這是因為 COVID-19 患者需要始終將 SpO2 讀數保持在 90-92% 以上,因此需要持續監測。 此外,為了遏制感染的傳播,對非接觸式紅外線測溫儀的需求大幅增加,最終導致生命徵象監測儀市場的細分市場成長。
本報告研究和分析了全球生命徵象監測儀市場,提供市場規模和預測、促進因素和挑戰、公司和產品概況等。
Vital Sign Monitors Market By Product Type (Standalone Monitoring Devices [Blood Pressure Monitoring Devices {Mercury Blood Pressure Monitors, Aneroid Blood Pressure Monitors, Automated Blood Pressure Monitors, And Others}, Pulse Oximeters {Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Bench Top Pulse Oximeters, And Wearable Pulse Oximeters}, Temperature Monitoring Devices {Digital Thermometers, Infrared Thermometers, And Others}, Others] And Combined Monitoring Devices), By End-User (Hospitals, Clinics, Home Care Settings, And Others), by geography is projected to grow at a significant CAGR forecast till 2030 due to the rising burden of geriatric population and increasing prevalence of lifestyle-associated chronic disorders.
The global vital sign monitors market was valued at USD 8.19 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 12.96 billion by 2030. The rise in demand for vital sign monitors is primarily attributed to the growing burden of the old age population across the globe, increase in the prevalence of a variety of lifestyle-associated disorders such as respiratory disorders, cardiology disorders, among others. Moreover, constant efforts of the key manufacturers for developing technologically advanced vital sign monitoring devices, and the rise in approval of the products portfolio, among others are the factors responsible for the growth of vital sign monitoring devices.
Vital Sign Monitors Market Dynamics:
Vital sign monitors are gaining momentum in recent years owing to the rising burden of the geriatric population worldwide. This is because old age people are at a higher risk of developing various chronic disorders which makes it necessary to continuously measure the performance of the vital organs. For instance, according to the statistics published in the United Nation's World Population Ageing in the year 2020, there were approximately 727 million persons in the world who were aged 65 years or over in the same year. Also, the same highlights estimated that by the year 2050, the overall old age population worldwide will double, reaching over 1.5 billion.
Additionally, the rising prevalence of lifestyle-associated disorders is also one of the leading factors responsible for the growing demand for vital sign monitoring devices. According to the World Health Organization (WHO), hypertension is a serious lifestyle disorder that significantly increases the risk of heart, brain, kidney, and other diseases. Moreover, as per the 2022 statistics published by the WHO, approximately 1.28 billion adults aged between 30 and 79 across the globe have hypertension or blood pressure.
Furthermore, an increase in product approval for various vital sign monitoring devices is also anticipated to bolster the market for vital sign monitoring devices. For instance, on February 10, 2022, CardiacSense received CE Mark for its medical-grade watch which is capable of detecting and remotely monitoring atrial fibrillation (AF) and heart rate variability (HRV).
Hence, all the aforementioned factors are projected to augment the global market for vital sign monitors during the forecasted period.
Certain factors such as high cost associated with the certain product type and user readiness and unresponsiveness of some monitoring devices are expected to limit the growth of the vital sign monitors market.
Additionally, the unprecedented COVID-19 pandemic had a positive impact on the vital sign monitoring devices market. This is because of the recent expansion in the use of vital sign monitors by the FDA to enable remote patient care during COVID-19 emergencies to reduce hospital visits in order to minimize the risk of coronavirus exposure. Moreover, the pandemic also allowed the local manufacturers to launch new products for remotely measuring the patient's body temperature, respiratory rate, and others. For instance, in June 2020, DetelPro, an Indian-based company launched an infrared thermometer at a very nominal price.
Vital Sign Monitors Market Segment Analysis:
Vital Sign Monitors Market By Product Type (Standalone Monitoring Devices [Blood Pressure Monitoring Devices {Mercury Blood Pressure Monitors, Aneroid Blood Pressure Monitors, Automated Blood Pressure Monitors, and Others}, Pulse Oximeters {Fingertip Pulse Oximeters, Handheld Pulse Oximeters, Bench_Top Pulse Oximeters, and Wearable Pulse Oximeters}, Temperature Monitoring Devices {Digital Thermometers, Infrared Thermometers, and Others}, Others] and Combined Monitoring Devices), By End-User (Hospitals, Clinics, Homecare Settings, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the vital sign monitors product segment, the standalone monitoring devices which are further sub-categorized into blood pressure monitoring devices, temperature monitoring devices, pulse oximeters, and others are expected to hold a significant market share during the forthcoming years. This is due to the wide availability of standalone devices in the market. Moreover, the standalone remote vital sign monitoring devices are available Over the Counter (OTC) which also increases the segmental market for vital sign monitors.
Also, the sudden outbreak of the COVID-19 pandemic has raised the demand for pulse oximeters. This is because a person with COVID-19 infection has to ensure that the SpO2 reading stays consistently at or above 90 to 92% which requires continuous monitoring. Moreover, to curb the spread of infection, the demand for non-contact infrared thermometers has increased considerably which ultimately leads to the segmental growth of the vital sign monitors market.
Additionally, the recent product launched in the standalone vital sign monitoring devices product arena will further spur the segmental market of vital sign monitors. For instance, in January 2022, telehealth company Tyto Care has launched its Fingertip Pulse Oximeter (SpO2) medical device for checking blood oxygen saturation levels and heart rate remotely.
Thus all the above-mentioned factors will contribute to the market growth of vital sign monitors.
North America is expected to dominate the Overall Vital Sign Monitors Market:
North America is expected to dominate the overall vital sign monitors market during the forecast period. This domination is due to the growing demand for advanced technologies in remote patient monitoring devices or vital sign monitors, the increasing chronic disease in the region, and others that are driving the regional growth. Moreover, the rising prevalence of respiratory diseases, increased R&D funding, favourable reimbursement for these devices, and the presence of an advanced healthcare system are also the fuelling factors for the vital sign monitors market in the region.
For instance, according to the Centers for Disease Control and Prevention (CDC) 2022 data, approximately 4.6 % of the total American population have been diagnosed with COPD, emphysema, or chronic bronchitis.
Also, as per the data revealed in the year 2023 by the CDC, nearly half of adults in the United States (47%, or 116 million) have hypertension.
Therefore, rising cases of chronic disorders are likely to raise the demand for vital sign monitors in the region.
In addition, the presence of key market players such as Masimo, Nonin Medical Inc, Medtronic, among others is also expected to boost the vital sign monitors market. Also, advanced product launches and commercialization agreements among the key companies are further expected to fuel the market. For instance, recently in March 2022, Nonin Medical, Inc. launched two new disposable products - a single-use wristband and a sensor for use with Nonin's WristOx2 3150, wrist-worn pulse oximeter (SpO2). Nonin's new disposables offer immediate and cost-effective solutions to reduce healthcare provider and patient exposure to infectious agents during the pandemic. Thus, these are some of the factors contributing to the market growth of vital sign monitors in the region.
Further, Europe and the Asia-Pacific region have the future potential growth for the global vital sign monitors market. This is due to the rising burden of chronic diseases in the European region countries and Asia countries also. In all countries, chronic illness rates have been increasing. Several reports have been released annually, mentioning that significant portions of the population in the European Union and the APAC suffer through more than one chronic disorder, such as hypertension, cardiac arrhythmias, sleep apnea, asthma, diabetes, hyperlipidemia, and chronic obstructive pulmonary disease (COPD), for a prolonged period, thus there is an enormous potential for vital signs monitors market growth.
Vital Sign Monitors Market Key Players:
Some of the key market players operating in the Vital Sign Monitors market include Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION., Nonin Medical, Omron, ACCOSON, Advin Health Care, Lepu Medical Technology, TytoCare Ltd., VYAIRE, SCHILLER, SunTech Medical, Inc., Welch Allyn Inc., Medtronic, GENERAL ELECTRIC COMPANY, Contec Medical Systems Limited, Biobeat, Honsun, Rudolf Riester GmbH, Promed Technology, Infinium Medical, and others.
Recent Developmental Activities in the Vital Sign Monitors Market:
In November 2020, Masimo received CE marking for its Radius VSM(TM), a wearable, tetherless vital signs monitor, and is released in limited European markets.
In October 2020, Nihon Kohden launched NK-HealthProtect(TM) during COVID-19 in the US. NK-HealthProtect(TM) Patient Triage Solution is a complete kit that includes SVM-7200 Vital Signs Monitor to help evaluate patients potentially suffering from COVID-19.
In July 2020, Philips and BioIntelliSense entered into a strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home.
Key Takeaway from the Vital Sign Monitors Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Vital Sign Monitors market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Vital Sign Monitors Market.
Various opportunities are available for the other competitor in the Vital Sign Monitors Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Vital Sign Monitors market growth in the coming future?
Target Audience who can be benefited from the Vital Sign Monitors Market Report Study
Vital Sign Monitors providers
Research organizations and consulting companies
Vital Sign Monitors-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Vital Sign Monitors
Various End-users who want to know more about the Vital Sign Monitors Market and the latest technological developments in the Vital Sign Monitors market.
Frequently Asked Questions for Vital Sign Monitors Market:
Vital signs monitor are the devices that measure the basic medical indicators of health such as temperature, pulse, breathing, and blood pressure. Most of these monitors can store and record thousands of pieces of information.
The global vital sign monitors market was valued at USD 8.19 billion in 2023, growing at a CAGR of 7.94% during the forecast period from 2024 to 2030, to reach USD 12.96 billion by 2030.
The major factors driving the demand for vital sign monitors are the rising worldwide prevalence of various lifestyle-associated chronic disorders, the sudden outbreak of the COVID-19 pandemic, the increasing old age population, and recent product approvals, among others.
Some of the key market players operating in the Vital Sign Monitors market include Masimo, Koninklijke Philips N.V., NIHON KOHDEN CORPORATION., Nonin Medical, Omron, ACCOSON, Advin Health Care, Lepu Medical Technology, TytoCare Ltd., VYAIRE, SCHILLER, SunTech Medical, Inc., Welch Allyn Inc., Medtronic, GENERAL ELECTRIC COMPANY, Contec Medical Systems Limited, Biobeat, Honsun, Rudolf Riester GmbH, Promed Technology, Infinium Medical, and others.
North America is expected to dominate the overall vital sign monitors market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in remote patient monitoring devices or vital sign monitors, the increasing chronic disease in the region, and others that are driving the regional growth. Moreover, the rising prevalence of respiratory diseases, increased R&D funding, favourable reimbursement for these devices, and the presence of an advanced healthcare system are also the fuelling factors for the vital sign monitors market in the region.
9.179Rudolf Riester GmbH